Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Leukemia, Myeloid, Acute 68Leukemia 56Myelodysplastic Syndromes 53Lymphoma 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Lymphoma, Non-Hodgkin 43Multiple Myeloma 40Hodgkin Disease 39Leukemia, Lymphocytic, Chronic, B-Cell 35Congenital Abnormalities 30Lymphoma, Follicular 28Lymphoma, Large B-Cell, Diffuse 27Lymphoma, Mantle-Cell 26Neoplasms, Plasma Cell 25Lymphoma, B-Cell, Marginal Zone 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Burkitt Lymphoma 23Myeloproliferative Disorders 22Lymphoma, Large-Cell, Immunoblastic 22Leukemia, Myelomonocytic, Chronic 22Blast Crisis 22Leukemia, Myeloid, Chronic-Phase 21Leukemia, Myeloid, Accelerated Phase 21Primary Myelofibrosis 19Lymphoma, T-Cell, Cutaneous 15Hematologic Neoplasms 15Graft vs Host Disease 15Dendritic Cell Sarcoma, Interdigitating 14Anemia, Refractory, with Excess of Blasts 14Waldenstrom Macroglobulinemia 13

Interventions

sargramostim 3dinutuximab 3Vincristine 3Topotecan 3Stem Cell Transplantation 3Radiation 3Platinum 3Melphalan 3Isotretinoin 3Doxorubicin 3Cyclophosphamide 3Congresses as Topic 3Colony-Stimulating Factors 3Cisplatin 31,2-diaminocyclohexaneplatinum II citrate 3Temozolomide 2Irinotecan 2Etoposide 2Busulfan 23-Iodobenzylguanidine 2temsirolimus 1etoposide phosphate 1Thiotepa 1Specimen Handling 1Sirolimus 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Peripheral Blood Stem Cell Transplantation 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Ganglioneuroblastoma × Busulfan × Clear all
NCT01175356 2026-01-23

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Children's Oncology Group

Phase 1 Completed
99 enrolled 11 charts
CNS

Neuroblastoma, Ganglioneuroblastoma

NCT01798004 2024-07-15

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Children's Oncology Group

Phase 1 Completed
150 enrolled 9 charts
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡